LEP and chronic kidney disease: During a 12 month follow-up of patients under cKD, De Amicis et al. [180] did not observe any change in leptin and ghrelin plasmatic levels independently from age and clinical conditions; thus, it seems presumable that cKD action does not rely on these peptide pathways.